RhoVac AB
http://www.rhovac.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From RhoVac AB
RhoVac Seeks Path Forward After Phase IIb Prostate Cancer Disappointment
Despite a seemingly sound mechanism and promising early data, the Swedish firm’s sole clinical asset has flunked a mid-stage prostate cancer trial, prompting a search for responsive subgroups.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
- Other Names / Subsidiaries
-
- RhoVac Aps
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice